Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Glaucoma

Chris J. Hong and Graham E. Trope
CMAJ September 08, 2015 187 (12) E398-E399; DOI: https://doi.org/10.1503/cmaj.140401
Chris J. Hong
Faculty of Medicine (Hong), University of Ottawa, Ottawa, Ont.; Department of Ophthalmology and Vision Sciences (Trope), University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Graham E. Trope
Faculty of Medicine (Hong), University of Ottawa, Ottawa, Ont.; Department of Ophthalmology and Vision Sciences (Trope), University of Toronto, Toronto, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: graham.trope@uhn.ca
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Glaucoma is the most common cause of irreversible blindness in the world

Glaucoma affects 400 000 Canadians and 67 million people worldwide. Nevertheless, for 50% of patients with glaucoma in developed countries, the condition remains undiagnosed.1

Glaucoma is an optic neuropathy with characteristic damage to the optic nerve leading to loss of visual field

Glaucoma causes the death of retinal ganglion cells by apoptosis, which leads to the loss of optic nerve axons.2 It is most often associated with, but is not defined by, high intraocular pressure and is diagnosed by characteristic fundoscopic findings (Figure 1) and visual field defects.2

Figure 1:
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1:

Fundoscopy showing glaucomatous disk (white arrow) with severe cupping (black arrow) from loss of neuroretinal rim.

Primary open-angle glaucoma is a slow and silent thief of vision

Primary open-angle glaucoma is the most common type of glaucoma in developed countries (85%–90% of cases).3 It is characterized by slow, painless loss of the visual field, with sparing of the central vision until the late stages, which explains why patients often present late.2 Routine eye examinations are important for early detection of glaucoma, before irreversible loss of vision, especially for those at higher risk (e.g., older people and those with a family history of glaucoma).4 Black people and those with myopia are also at greater risk.5

Patients require timely therapy to slow the progression of open-angle glaucoma

In most cases, glaucoma eye drops (e.g., latanoprost, a prostaglandin analogue) effectively slow progression of the condition.6 However, patient education is critical: in one multicentre survey, 61.7% of patients were either noncompliant with their medication or had improper administration technique.7 Laser therapy or surgical interventions (e.g., trabeculectomy) are other options, if required.6

Acute angle-closure glaucoma is a medical emergency requiring prompt referral to an ophthalmologist

Primary angle closure is generally bilateral, although 90% of acute attacks are unilateral, caused by iris bombe leading to a closed angle. During an acute crisis, the patient presents with severe eye pain; red eye; blurred vision; edematous cornea; a fixed, mid-dilated vertically oval, nonreactive pupil; and high intraocular pressure.8 After the pressure is lowered with drops and medications, laser iridotomy is performed to relieve the pupil block.8 Prophylactic laser iridotomy or lens extraction that widens the angle can be used to prevent pupil block.8

CMAJ invites submissions to “Five things to know about …” Submit manuscripts online at http://mc.manuscriptcentral.com/cmaj

Footnotes

  • See also www.cmaj.ca/lookup/doi/10.1503/cmaj.140685

  • This article has been peer reviewed.

  • Competing interests: None declared.

References

  1. ↵
    1. Anraku A,
    2. Jin YP,
    3. Butty Z,
    4. et al
    . The Toronto epidemiology glaucoma survey: a pilot study. Can J Ophthalmol 2011;46:352–7.
    OpenUrlCrossRefPubMed
  2. ↵
    1. Quigley HA
    . Glaucoma. Lancet 2011;377:1367–77.
    OpenUrlCrossRefPubMed
  3. ↵
    1. Cassard SD,
    2. Quigley HA,
    3. Gower EW,
    4. et al
    . Regional variations and trends in the prevalence of diagnosed glaucoma in the Medicare population. Ophthalmology 2012;119:1342–51.
    OpenUrlCrossRefPubMed
  4. ↵
    Canadian Ophthalmological Society evidence-based clinical practice guidelines for the management of glaucoma in the adult eye. Can J Ophthalmol 2009;44 Suppl 1:S1–93.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Boland MV,
    2. Quigley HA
    . Risk factors and open-angle glaucoma: classification and application. J Glaucoma 2007;16:406–18.
    OpenUrlCrossRefPubMed
  6. ↵
    AAO Glaucoma Panel. Primary open-angle glaucoma suspect. San Francisco: American Academy of Ophthalmology; 2010. Available: http://one.aao.org/preferred-practice-pattern/primary-openangle-glaucoma-suspect-ppp--october-20 (accessed 2014 Nov. 17).
  7. ↵
    1. Kholdebarin R,
    2. Campbell RJ,
    3. Jin YP,
    4. et al
    . Multicenter study of compliance and drop administration in glaucoma. Can J Ophthalmol 2008; 43: 454–61.
    OpenUrlCrossRefPubMed
  8. ↵
    AAO Glaucoma Panel. Primary angle closure. San Francisco: American Academy of Ophthalmology; 2010. Available: http://one.aao.org/preferred-practice-pattern/primary-angle-closure-ppp--october-2010 (accessed 2014 Nov. 17).
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 187 (12)
CMAJ
Vol. 187, Issue 12
8 Sep 2015
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Glaucoma
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Glaucoma
Chris J. Hong, Graham E. Trope
CMAJ Sep 2015, 187 (12) E398-E399; DOI: 10.1503/cmaj.140401

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Glaucoma
Chris J. Hong, Graham E. Trope
CMAJ Sep 2015, 187 (12) E398-E399; DOI: 10.1503/cmaj.140401
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Glaucoma is the most common cause of irreversible blindness in the world
    • Glaucoma is an optic neuropathy with characteristic damage to the optic nerve leading to loss of visual field
    • Primary open-angle glaucoma is a slow and silent thief of vision
    • Patients require timely therapy to slow the progression of open-angle glaucoma
    • Acute angle-closure glaucoma is a medical emergency requiring prompt referral to an ophthalmologist
    • Footnotes
    • References
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • A woman with a family history of glaucoma
  • Highlights
  • PubMed
  • Google Scholar

Cited By...

  • Non-invasive Intraocular pressure monitoring with contact lens
  • Google Scholar

More in this TOC Section

  • A blistering variant of phlegmasia cerulea dolens from underlying squamous cell lung cancer
  • Parechovirus infections in infants
  • Radiation dermatitis in a patient treated for hepatocarcinoma
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Emergency medicine
    • Family medicine, general practice, primary care
    • Ophthalmology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire